Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Inside Coke's covert campaign to downplay the risks of sugary soda. A new book shows how the company misled America.

Slow motion vertical 4k footage. adolescence obesity stock videos & royalty-free footage A teenage girl is consumed by social networks in a fast food cafe. Modern youth addictions are unhealthy ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5. ... The news sent Roche's stock up more than 4% in trading Wednesday, and Zealand's stock skyrocketed 40% on ...